Advertisement
Perspective| Volume 102, P196-202, January 2021

Could SARS-CoV-2-induced lung injury be attenuated by vitamin D?

  • Author Footnotes
    1 These authors contributed equally to this study.
    Dongqiong Xiao
    Footnotes
    1 These authors contributed equally to this study.
    Affiliations
    Department of Pediatrics/Key Laboratory of Birth Defects and Related Diseases of Women and Children (Ministry of Education), West China Second University Hospital, Sichuan University, Chengdu 610041, China
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally to this study.
    Xihong Li
    Footnotes
    1 These authors contributed equally to this study.
    Affiliations
    Department of Pediatrics/Key Laboratory of Birth Defects and Related Diseases of Women and Children (Ministry of Education), West China Second University Hospital, Sichuan University, Chengdu 610041, China
    Search for articles by this author
  • Xiaojuan Su
    Affiliations
    Department of Pediatrics/Key Laboratory of Birth Defects and Related Diseases of Women and Children (Ministry of Education), West China Second University Hospital, Sichuan University, Chengdu 610041, China
    Search for articles by this author
  • Dezhi Mu
    Affiliations
    Department of Pediatrics/Key Laboratory of Birth Defects and Related Diseases of Women and Children (Ministry of Education), West China Second University Hospital, Sichuan University, Chengdu 610041, China
    Search for articles by this author
  • Yi Qu
    Correspondence
    Corresponding author at: Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
    Affiliations
    Department of Pediatrics/Key Laboratory of Birth Defects and Related Diseases of Women and Children (Ministry of Education), West China Second University Hospital, Sichuan University, Chengdu 610041, China
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally to this study.
Open AccessPublished:October 27, 2020DOI:https://doi.org/10.1016/j.ijid.2020.10.059

      Highlights

      • As a counter-regulatory arm of the renin–angiotensin system (RAS), ACE2 plays critical roles in the pathogenesis of ARDS and acute lung injury.
      • The affinity of the spike protein receptor binding domain (RBD) of SARS-CoV-2 for human ACE2 (hACE2) largely determines the degree of clinical symptoms in those infected by SARS-CoV-2.
      • Vitamin D was found to affect ACE2—the same target for SARS-CoV-2; we therefore propose that vitamin D might alleviate ARDS and acute lung injury induced by SARS-CoV-2 through modulating ACE2.

      Abstract

      A novel coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) has been confirmed as having the capacity to transmit from humans to humans, causing acute respiratory distress syndrome (ARDS) and acute lung injury. Angiotensin converting enzyme-2 (ACE2) is known to be expressed on type II pneumocytes. As a counter-regulatory arm of the renin–angiotensin system (RAS), ACE2 plays critical roles in the pathogenesis of ARDS and acute lung injury.
      The affinity of the spike protein receptor binding domain (RBD) of SARS-CoV-2 for human ACE2 (hACE2) largely determines the degree of clinical symptoms after infection by SARS-CoV-2. Previous studies have shown that regulating the ACE2/RAS system is effective in the treatment of severe acute respiratory syndrome coronavirus (SARS-CoV)-induced ARDS and acute lung injury. Since ACE2 is the host cell receptor for both SARS-CoV-2 and SARS-CoV, regulating the ACE2/RAS system may alleviate ARDS and acute lung injury caused by SARS-CoV-2 as well as SARS-CoV. Vitamin D was found to affect ACE2, the target of SARS-CoV-2; therefore, we propose that vitamin D might alleviate ARDS and acute lung injury induced by SARS-CoV-2 by modulating ACE2.

      Abbreviations:

      ACE2 (angiotensin converting enzyme-2), Ang I (angiotensin I), Ang1-9 (angiotensin 1-9), Ang Ⅱ (angiotensin Ⅱ), Ang1-7 (angiotensin 1-7), AP-1 (activation protein 1), ARDS (acute respiratory distress syndrome), ALI (acute lung injury), RAS (renin-angiotensin system), RBD (receptor-binding domain), RBM (receptor-binding motif), 2019-nCoV (novel coronavirus), SARS-CoV (SARS coronavirus), VDR (vitamin D receptor), hACE2 (human ACE2), TGF-β (transforming growth factor β), IL-8 (interleukin-8), TNF-α (tumor necrosis factor alpha), IFN-α (interferon alpha), CCL3 (chemokine (C-C motif) ligand 3), VDREs (vitamin D responsive elements), RSV (respiratory syncytial virus), HBDs (β‐defensins)

      Keywords

      Introduction and general physiology

      A novel coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) had caused 4,761,559 confirmed cases and 317,529 confirmed deaths worldwide, as of May 20, 2020 (https://www.who.int/emergencies/diseases/novel-coronavirus-2019). Many of the symptoms caused by SARS-CoV-2 are similar to those caused by severe acute respiratory syndrome coronavirus (SARS-CoV), especially acute respiratory distress syndrome (ARDS) (
      • Li X.
      • Wang W.
      • Zhao X.
      • Zai J.
      • Zhao Q.
      • Li Y.
      • et al.
      Transmission dynamics and evolutionary history of 2019-nCoV.
      ). Previous studies have reported that ARDS is the primary cause of mortality and morbidity in intensive care units (ICUs) (
      • Liu P.
      • Tan X.-Z.
      2019 Novel coronavirus (2019-nCoV) pneumonia.
      ,
      • Liu W.
      • Morse J.S.
      • Lalonde T.
      • Xu S.
      Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV.
      ,
      • Liu Y.
      • Yang Y.
      • Zhang C.
      • Huang F.
      • Wang F.
      • Yuan J.
      • et al.
      Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury.
      ). ARDS is associated with increased alveolar epithelial permeability and pulmonary microvascular endothelial permeability, pulmonary edema, and pulmonary fibrosis (
      • Russell C.D.
      • Millar J.E.
      • Baillie J.K.
      Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.
      ). The SARS-CoV envelope-anchored spike protein has been shown to bind to the host receptor and then induce virus replication, and different structures of the SARS-CoV spike protein may bind to different target receptors (
      • Li X.
      • Wang W.
      • Zhao X.
      • Zai J.
      • Zhao Q.
      • Li Y.
      • et al.
      Transmission dynamics and evolutionary history of 2019-nCoV.
      ,
      • Li X.
      • Zai J.
      • Wang X.
      • Li Y.
      Potential of large’ first generation’ human-to-human transmission of 2019-nCoV.
      ,
      • Wu A.
      • Peng Y.
      • Huang B.
      • Ding X.
      • Wang X.
      • Niu P.
      • et al.
      Genome composition and divergence of the novel coronavirus (2019-nCoV) Originating in China.
      ). Thus, the surface structure of the spike protein is particularly important for the development of antiviral strategies (
      • Zumla A.
      • Hui D.S.
      • Azhar E.I.
      • Memish Z.A.
      • Maeurer M.
      Reducing mortality from 2019-nCoV: host-directed therapies should be an option.
      ).
      SARS-CoV-2 is a β-genus, single-stranded enveloped RNA virus (
      • Li X.
      • Wang W.
      • Zhao X.
      • Zai J.
      • Zhao Q.
      • Li Y.
      • et al.
      Transmission dynamics and evolutionary history of 2019-nCoV.
      ). The genome sequences suggest that SARS-CoV-2 is closely associated with SARS and related viruses that circulate in bats (
      • Li X.
      • Zai J.
      • Wang X.
      • Li Y.
      Potential of large’ first generation’ human-to-human transmission of 2019-nCoV.
      ). Almost 25% of the confirmed coronavirus disease 2019 (COVID-19) patients have been reported as having severe and underlying comorbidities (
      • Biscayart C.
      • Angeleri P.
      • Lloveras S.
      • Chaves T.d.S.S.
      • Schlagenhauf P.
      • Rodriguez-Morales A.J.
      The next big threat to global health? 2019 novel coronavirus (2019-nCoV): What advice can we give to travellers?—Interim recommendations January 2020, from the Latin-American society for Travel Medicine (SLAMVI).
      ).

      Evidence for the influence of angiotensin converting enzyme-2 (ACE2) on SARS-CoV-induced ARDS

      The SARS epidemic occurred in southern China and caused more than 8000 cases of infection worldwide in 2002–2003, with an approximately 10% fatality rate (
      • Li F.
      Receptor recognition and cross-species infections of SARS coronavirus.
      ). The receptor-binding motif (RBM) of the SARS-CoV spike protein connects directly with ACE2 residues (
      • Gui M.
      • Song W.
      • Zhou H.
      • Xu J.
      • Chen S.
      • Xiang Y.
      • et al.
      Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding.
      ,
      • Pak J.E.
      • Sharon C.
      • Satkunarajah M.
      • Auperin T.C.
      • Cameron C.M.
      • Kelvin D.J.
      • et al.
      Structural insights into immune recognition of the severe acute respiratory syndrome coronavirus S protein receptor binding domain.
      ) (Figure 1). Mutations in the RBM affect the interactions of the spike protein and ACE2. For example, mutations at residues 479 and 487 of the RBM control cross-species infections and human transmission of SARS-CoV, respectively (
      • Ge X.-Y.
      • Li J.-L.
      • Yang X.-L.
      • Chmura A.A.
      • Zhu G.
      • Epstein J.H.
      • et al.
      Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor.
      ,
      • Li F.
      Receptor recognition and cross-species infections of SARS coronavirus.
      ,
      • Pak J.E.
      • Sharon C.
      • Satkunarajah M.
      • Auperin T.C.
      • Cameron C.M.
      • Kelvin D.J.
      • et al.
      Structural insights into immune recognition of the severe acute respiratory syndrome coronavirus S protein receptor binding domain.
      ,
      • Struck A.-W.
      • Axmann M.
      • Pfefferle S.
      • Drosten C.
      • Meyer B.
      A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2.
      ). Furthermore, the affinity of the spike protein receptor binding domain (RBD) for human ACE2 (hACE2) predominantly determines the degree of clinical symptoms caused by SARS-CoV (
      • Gui M.
      • Song W.
      • Zhou H.
      • Xu J.
      • Chen S.
      • Xiang Y.
      • et al.
      Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding.
      ,
      • Mueller M.A.
      • Raj V.S.
      • Muth D.
      • Meyer B.
      • Kallies S.
      • Smits S.L.
      • et al.
      Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines.
      ).
      Figure 1
      Figure 1The RBM in the spike protein of SARS-CoV binding to human ACE2. The RBM (red) is the core of the RBD.
      ACE2 has been found to be expressed on viral target cells, such as type II pneumocytes and enterocytes (
      • Bertram S.
      • Glowacka I.
      • Mueller M.A.
      • Lavender H.
      • Gnirss K.
      • Nehlmeier I.
      • et al.
      Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease.
      ). After SARS-CoV binds to ACE2, it triggers receptor-mediated endocytosis and the transport of virions into the endosomes of type II pneumocytes (
      • Bertram S.
      • Glowacka I.
      • Mueller M.A.
      • Lavender H.
      • Gnirss K.
      • Nehlmeier I.
      • et al.
      Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease.
      ,
      • Gui M.
      • Song W.
      • Zhou H.
      • Xu J.
      • Chen S.
      • Xiang Y.
      • et al.
      Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding.
      ,
      • Haga S.
      • Nagata N.
      • Okamura T.
      • Yamamoto N.
      • Sata T.
      • Yamamoto N.
      • et al.
      TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds.
      ). Next, the virus replicates in the host cells, leading to downregulation of ACE2 (
      • Li X.
      • Zai J.
      • Wang X.
      • Li Y.
      Potential of large’ first generation’ human-to-human transmission of 2019-nCoV.
      ).
      ACE2 is a novel ACE homologue that acts as a counter-regulatory arm of the renin–angiotensin system (RAS) (
      • Imai Y.
      • Kuba K.
      • Penninger J.M.
      The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice.
      ). This molecule can convert angiotensin I (Ang I) to Ang1-9 and convert Ang Ⅱ to Ang1-7 (
      • Imai Y.
      • Kuba K.
      • Penninger J.M.
      The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice.
      ,
      • Kuba K.
      • Imai Y.
      • Penninger J.M.
      Angiotensin-converting enzyme 2 in lung diseases.
      ). When Ang Ⅱ binds to the AT1a receptor it induces increased alveolar epithelial permeability and pulmonary microvascular endothelial permeability, pulmonary edema, and pulmonary fibrosis. However, the opposite effects occur when Ang Ⅱ binds to the AT2 receptor. In addition, as a counter-regulatory arm of RAS, ACE2-Ang1-7 can bind to the Mas receptor to inhibit the above process and thus protect against lung injury (
      • Li Y.
      • Zeng Z.
      • Cao Y.
      • Liu Y.
      • Ping F.
      • Liang M.
      • et al.
      Angiotensin-converting enzyme 2 prevents lipopolysaccharide-induced rat acute lung injury via suppressing the ERK1/2 and NF-kappa B signaling pathways.
      ). The balance of Ang Ⅱ/Ang1-7 is commonly disrupted after infection with SARS-CoV; the ratio of Ang Ⅱ/Ang1-7 is increased due to decreased expression of ACE2, which can lead to acute lung injury and ARDS (
      • Wu Y.
      Compensation of ACE2 function for possible clinical management of 2019-nCoV-induced acute lung injury.
      ) (Figure 2).
      Figure 2
      Figure 2The role of ACE2 in acute lung injury.
      The SARS-CoV spike protein has been shown to bind to ACE2 and induce interleukin-8 (IL-8) release from lung cells by activating activation protein 1 (AP-1) (
      • Chen I.Y.
      • Chang S.C.
      • Wu H.-Y.
      • Yu T.-C.
      • Wei W.-C.
      • Lin S.
      • et al.
      Upregulation of the chemokine (C-C motif) ligand 2 via a severe acute respiratory syndrome coronavirus spike-ACE2 signaling pathway.
      ). Dysregulation of inflammatory cytokines may be involved in ARDS. High levels of proinflammatory cytokines, such as transforming growth factor β (TGFβ), IL-8, IL-6, tumor necrosis factor alpha (TNF-α), interferon alpha (IFN-α), IFN-β, IFN-γ, chemokine (C-C motif) ligand 3 (CCL3), CCL5, and CXCL10, have been detected in SARS-CoV infection (
      • Castilletti C.
      • Bordi L.
      • Lalle E.
      • Rozera G.
      • Poccia F.
      • Agrati C.
      • et al.
      Coordinate induction of IFN-alpha and -gamma by SARS-CoV also in the absence of virus replication.
      ,
      • Chen I.Y.
      • Chang S.C.
      • Wu H.-Y.
      • Yu T.-C.
      • Wei W.-C.
      • Lin S.
      • et al.
      Upregulation of the chemokine (C-C motif) ligand 2 via a severe acute respiratory syndrome coronavirus spike-ACE2 signaling pathway.
      ,
      • Zhang Y.C.
      • Li J.
      • Zhan Y.L.
      • Wu L.Q.
      • Yu X.Y.
      • Zhang W.J.
      • et al.
      Analysis of serum cytokines in patients with severe acute respiratory syndrome.
      ,
      • Ziegler T.
      • Matikainen S.
      • Ronkko E.
      • Osterlund P.
      • Sillanpaa M.
      • Siren J.
      • et al.
      Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune responses in cultured human monocyte-derived dendritic cells.
      ). CCL2 is associated with ARDS and pulmonary fibrosis (
      • Chen I.Y.
      • Chang S.C.
      • Wu H.-Y.
      • Yu T.-C.
      • Wei W.-C.
      • Lin S.
      • et al.
      Upregulation of the chemokine (C-C motif) ligand 2 via a severe acute respiratory syndrome coronavirus spike-ACE2 signaling pathway.
      ). CCL2 is overexpressed in SARS patients.
      • Chen I.Y.
      • Chang S.C.
      • Wu H.-Y.
      • Yu T.-C.
      • Wei W.-C.
      • Lin S.
      • et al.
      Upregulation of the chemokine (C-C motif) ligand 2 via a severe acute respiratory syndrome coronavirus spike-ACE2 signaling pathway.
      ) reported that SARS-CoV-induced casein Ⅱ (CK Ⅱ)-mediated phosphorylation of the ACE2 receptor activated ERK1/2 and upregulated AP-1/CCL2, thus leading to ARDS (Figure 3). Collectively, many studies have reported that ACE2 plays important roles in SARS-CoV-induced ARDS.
      Figure 3
      Figure 3The role of ACE2/CCL2 signaling in lung fibrosis in SARS.

      ACE2 protects the lung from acute injury

      ACE2 overexpression can protect the lung from acute injury caused by viral and bacterial infections. Zou et al. demonstrated that H5N1 flu infection-induced lung injury could be alleviated by administrating recombinant hACE2 protein (
      • Zou Z.
      • Yan Y.
      • Shu Y.
      • Gao R.
      • Sun Y.
      • Li X.
      • et al.
      Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections.
      ). Kuka et al. showed that higher levels of ACE2 are associated with better outcomes for coronavirus diseases (
      • Kuba K.
      • Imai Y.
      • Penninger J.M.
      Angiotensin-converting enzyme 2 in lung diseases.
      ). In addition, overexpression of ACE2 alleviated lipopolysaccharide (LPS)-induced ARDS by activating the Ang1-7/Mas signaling pathway (
      • Li Y.
      • Zeng Z.
      • Cao Y.
      • Liu Y.
      • Ping F.
      • Liang M.
      • et al.
      Angiotensin-converting enzyme 2 prevents lipopolysaccharide-induced rat acute lung injury via suppressing the ERK1/2 and NF-kappa B signaling pathways.
      ).

      ACE2 might affect SARS-CoV-2-induced ARDS: laboratory studies

      SARS-CoV-2 viral infection can cause ARDS and acute lung injury, which are similar to those caused by SARS-CoV (
      • Jin Y.-H.
      • Cai L.
      • Cheng Z.-S.
      • Cheng Z.-S.
      • Deng T.
      • Fan Y.-P.
      • et al.
      A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version).
      ). ACE2 is the host cell receptor for both SARS-CoV-2 and SARS-CoV (
      • Li F.
      Receptor recognition and cross-species infections of SARS coronavirus.
      ,
      • Wan Y.
      • Shang J.
      • Graham R.
      • Baric R.S.
      • Li F.
      Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS.
      ,
      • Zhou P.
      • Yang X.-L.
      • Wang X.-G.
      • Hu B.
      • Zhang L.
      • Zhang W.
      • et al.
      A pneumonia outbreak associated with a new coronavirus of probable bat origin.
      ). Importantly, when the RBD binds to hACE2 with strong affinity, the spike protein mediates viral entry into pneumocytes with high efficiency (
      • Wan Y.
      • Shang J.
      • Graham R.
      • Baric R.S.
      • Li F.
      Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS.
      ).
      • Wrapp D.
      • Wang N.
      • Corbett K.S.
      • Goldsmith J.A.
      • Hsieh C.L.
      • Abiona O.
      • et al.
      Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.
      ) found that the affinity of the SARS-CoV-2 spike protein for binding to ACE2 was almost 20 times higher than that of the SARS-CoV spike protein, explaining why SARS-CoV-2 has a higher infection rate than SARS-CoV. A study by
      • Bao L.
      • Deng W.
      • Huang B.
      • Gao H.
      • Liu J.
      • Ren L.
      • et al.
      The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.
      ) revealed that SARS-CoV-2 replication could be detected in the lungs of mice with hACE2 that had been infected with SARS-CoV-2. These mice presented the typical histopathology of interstitial pneumonia, with infiltration of high levels of macrophages and lymphocytes into the alveolar interstitium. In addition, SARS-CoV-2 antigens could be detected in bronchial epithelial cells, macrophages, and alveolar epithelia. However, the above phenomenon was not found in wild-type mice with SARS-CoV-2 infection, suggesting that ACE2 is the key factor mediating SARS-CoV-2-induced lung damage.
      Since ACE2 is the target receptor for both SARS-CoV-2 and SARS-CoV, we hypothesize that the pathogenic mechanism of the two viruses might be very similar (
      • Wu Y.
      Compensation of ACE2 function for possible clinical management of 2019-nCoV-induced acute lung injury.
      ). Therefore, upregulating ACE2 and inhibiting RAS may alleviate ARDS and acute lung injury caused by SARS-CoV-2 as well as SARS-CoV (
      • Wu Y.
      Compensation of ACE2 function for possible clinical management of 2019-nCoV-induced acute lung injury.
      ).
      • Xie X.D.
      • Chen J.Z.
      • Wang X.X.
      • Zhang F.R.
      • Liu Y.R.
      Age- and gender-related difference of ACE2 expression in rat lung.
      ) investigated ACE2 expression in the lungs of a rodent model. These researchers found that the decrease in ACE2 was relatively slight between the young adult and the middle-aged groups, but the decrease was significant in older male rats compared with younger rats. This decrease in ACE2 with age may parallel the increase in COVID-19-related mortality in the older population.

      ACE2 might affect SARS-CoV-2-induced ARDS: clinical studies

      As the host cell receptor for SARS-CoV-2, ACE2 exists as a dimer that includes the N-terminal peptidase domain (PD) and the C-terminal collectrin-like domain (CLD) (
      • Zhang X.
      • Li S.
      • Niu S.
      ACE2 and COVID-19 and the resulting ARDS.
      ). The PD of ACE2 recognizes the spike protein of SARS-CoV-2, and the CLD of ACE2 is cleaved by proteases such as transmembrane serine protease 2 (TMPRSS2), thus promoting SARS-CoV-2 spike protein-mediated entry into cells (
      • Senapati S.
      • Kumar S.
      • Singh A.K.
      • Banerjee P.
      • Bhagavatula S.
      Assessment of risk conferred by coding and regulatory variations of TMPRSS2 and CD26 in susceptibility to SARS-CoV-2 infection in human.
      ). Specifically, decreased expression of proteins such as ACE2 and TMPRSS2 in the airway epithelium in children may reduce viral entry, which might be the reason why SARS-CoV-2 leads to decreased lung injury in children compared with adults (
      • Lingappan K.
      • Karmouty-Quintana H.
      • Davies J.
      • Akkanti B.
      • Harting M.T.
      Understanding the age divide in COVID-19: why are children overwhelmingly spared?.
      ). A study by Bobeck et al. reported that Ang II, an inhibitor of the RAS system, was safely used in a COVID-19 patient with cardiomyopathy and vasodilatory shock, with a rapid improvement in her hemodynamics and vasopressor requirement without adverse effects (
      • Bobeck K.A.
      • Holtzclaw A.W.
      • Brown T.E.
      • Clark P.A.
      Effective use of angiotensin II in coronavirus disease 19-associated mixed shock state: a case report.
      ). In addition, Cheng et al. found that 44 patients with ARDS tolerated rhACE2 (
      • Cheng H.
      • Wang Y.
      • Wang G.Q.
      Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
      ).

      The role of ACE polymorphisms in COVID-19

      Since the affinity of the spike protein of SARS-CoV-2 for ACE2 predominantly determines the symptoms of patients with COVID-19, ACE allele frequency might affect the morbidity, infection course, severity, and mortality of COVID-19 (
      • Guo X.
      • Chen Z.
      • Xia Y.
      • Lin W.
      • Li H.
      Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2).
      ,
      • Sieńko J.
      • Kotowski M.
      • Bogacz A.
      • Lechowicz K.
      • Drożdżal S.
      • Rosik J.
      • et al.
      COVID-19: The influence of ACE genotype and ACE-I and ARBs on the course of SARS-CoV-2 infection in elderly patients.
      ,
      • Taha M.M.
      • Shahy E.M.
      • Mahdy-Abdallah H.
      • Ibrahim K.S.
      • El Tahlawy E.M.
      Evaluation of the effect of serum cystatin-C and ACE I/D and ACE G2350A polymorphisms on kidney function among hypertensive sewage workers.
      ). A study by Guo etal. revealed that the ACE structure could be changed by altered amino acids in missense variants. The His378Arg (rs142984500) mutant is a weak enhancer and the Ser19Pro (rs73635825) mutant is a strong enhancer of SARS-CoV-2 S-protein binding. The His378Arg (rs142984500) mutant may not only reduce the activity of ACE2 peptidase but may also affect the process of SARS-CoV-2 S-protein and ACE2 binding. Additionally, the Ser19Pro (rs73635825) alteration may destabilize the helix of ACE2, affecting contact with the S-protein. Mutations such as Lys341Arg, Asp206Gly, Ile468Val, Arg219Cys/His, and Gly211Arg may significantly destabilize the local structure, and some of these mutations may have a minor effect on S-protein binding. The distribution of 12 characterized ACE2 missense variants in different populations was also identified by this study. Missense variants were present in East Asian (rs191860450), South Asian (rs751603885 and rs14877180), African (rs149039346, rs73635825, rs147311723, and rs138390800) and European (rs148771870) populations (
      • Guo X.
      • Chen Z.
      • Xia Y.
      • Lin W.
      • Li H.
      Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2).
      ). These findings might help us to recognize individuals with an increased risk of COVID-19.

      Inflammatory cytokines induced by SARS-CoV-2

      The major cytokines induced by SARS-CoV-2 include IL-2, IL-4, IL-6, IL-7, IL-10, granulocyte colony stimulating factor (G-SCF), inducible protein-10 (IP-10), monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein 1 alpha (MIP1A), tumour necrosis factor α (TNF-α), and interferon-γ (IFN-γ), which were observed at high levels in severe COVID-19 patients (
      • Hu B.
      • Huang S.
      • Yin L.
      The cytokine storm and COVID-19.
      ,
      • Song P.
      • Li W.
      • Xie J.
      • Hou Y.
      • You C.
      Cytokine storm induced by SARS-CoV-2.
      ,
      • Wang J.
      • Jiang M.
      • Chen X.
      • Montaner L.J.
      Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts.
      ,
      • Ye Q.
      • Wang B.
      • Mao J.
      The pathogenesis and treatment of the’ cytokine storm’ in COVID-19.
      ).
      Collectively, SARS-CoV-2 primarily enters type Ⅱ pneumocytes with ACE2 and replicates with the help of TMPRSS2. Next, the replicated SARS-CoV-2 induces a cytokine storm, contributing to hyperinflammation and alveolar edema, and ultimately leading to ARDS.

      Could SARS-CoV-2-induced lung injury be attenuated by vitamin D?

      Vitamin D3 is mainly produced in the skin after exposure to ultraviolet rays from sunlight (
      • Teymoori-Rad M.
      • Shokri F.
      • Salimi V.
      • Marashi S.M.
      The interplay between vitamin D and viral infections.
      ). The active form of vitamin D, 1,25(OH)D (1,25 dihydroxy vitamin D), binds to the vitamin D receptor (VDR) to play anti-inflammatory and immune regulatory roles (
      • Gou X.
      • Pan L.
      • Tang F.
      • Gao H.
      • Xiao D.
      The association between vitamin D status and tuberculosis in children: a meta-analysis.
      ,
      • Xiao D.
      • Zhang X.
      • Ying J.
      • Zhou Y.
      • Li X.
      • Mu D.
      • et al.
      Association between vitamin D status and sepsis in children: a meta-analysis of observational studies.
      ). VDR interacts with 1,25(OH)D and then binds to vitamin D responsive elements (VDREs) to inhibit or promote the expression of target genes, such as enhancement of ACE2 expression (
      • Cui C.
      • Xu P.
      • Li G.
      • Qiao Y.
      • Han W.
      • Geng C.
      • et al.
      Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: role of renin-angiotensin system.
      ). Vitamin D deficiency is associated with increased pulmonary inflammation and ARDS in a mouse model; however, its effect is unclear in humans.
      • Fitzgerald M.
      • Shyamsundar M.
      • McNamee J.J.
      • Thickett D.R.
      • O’Kane C.M.
      • McAuley D.F.
      Vitamin D deficiency drives pulmonary inflammation in a human model of the acute respiratory distress syndrome induced by inhaled lipopolysaccharide in healthy volunteers.
      ) found that healthy volunteers with vitamin D deficiency had increased pulmonary inflammation after LPS inhalation.
      • Ilie P.C.
      • Stefanescu S.
      • Smith L.
      The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality.
      ) found a negative correlation between vitamin D level and the number of COVID-19 cases in some countries, including Iceland, Norway, Sweden, Finland, Denmark, the UK, Ireland, the Netherlands, Belgium, Germany, France, Switzerland, Italy, Spain, Estonia, Czech Republic, Slovakia, Hungary, Turkey, and Portugal. Furthermore, a negative correlation between vitamin D levels and the number of confirmed deaths caused by COVID-19 was also found in this study. There have been no actual data from the Chinese COVID-19 outbreak in relation to vitamin D levels until now. Vitamin D deficiency is common worldwide in all age groups due to decreased sun exposure and cutaneous synthesis, especially in northern regions. In particular, vitamin D deficiency is common among people during the winter and spring (particularly in the northern communities), especially in older and obese people (
      • Orwoll E.
      • Nielson C.M.
      • Marshall L.M.
      • Lambert L.
      • Holton K.F.
      • Hoffman A.R.
      • et al.
      Vitamin D deficiency in older men.
      ). We speculate that the outbreak of COVID-19 in winter and spring may be partly due to higher vitamin D deficiency in these seasons.
      Many studies have reported that vitamin D plays an important role in viral infections, such as those of the cold virus (
      • Martineau A.R.
      • Jolliffe D.A.
      • Greenberg L.
      • Aloia J.F.
      • Bergman P.
      • Dubnov-Raz G.
      • et al.
      Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis.
      ,
      • Science M.
      • Maguire J.L.
      • Russell M.L.
      • Smieja M.
      • Walter S.D.
      • Loeb M.
      Low serum 25-hydroxyvitamin D level and risk of upper respiratory tract infection in children and adolescents.
      ), rhinovirus (
      • Schogler A.
      • Muster R.J.
      • Kieninger E.
      • Casaulta C.
      • Tapparel C.
      • Jung A.
      • et al.
      Vitamin D represses rhinovirus replication in cystic fibrosis cells by inducing LL-37.
      ), influenza virus (
      • Khare D.
      • Godbole N.M.
      • Pawar S.D.
      • Mohan V.
      • Pandey G.
      • Gupta S.
      • et al.
      Calcitriol 1, 25 OH 2 D3 pre- and post-treatment suppresses inflammatory response to influenza A (H1N1) infection in human lung A549 epithelial cells.
      ,
      • Lee M.-D.
      • Lin C.-H.
      • Lei W.-T.
      • Chang H.-Y.
      • Lee H.-C.
      • Yeung C.-Y.
      • et al.
      Does vitamin D deficiency affect the immunogenic responses to influenza vaccination? A systematic review and meta-analysis.
      ,
      • Schogler A.
      • Muster R.J.
      • Kieninger E.
      • Casaulta C.
      • Tapparel C.
      • Jung A.
      • et al.
      Vitamin D represses rhinovirus replication in cystic fibrosis cells by inducing LL-37.
      ), respiratory syncytial virus (RSV) (
      • Teymoori-Rad M.
      • Shokri F.
      • Salimi V.
      • Marashi S.M.
      The interplay between vitamin D and viral infections.
      ), and adenovirus (
      • Teymoori-Rad M.
      • Shokri F.
      • Salimi V.
      • Marashi S.M.
      The interplay between vitamin D and viral infections.
      ). Therefore, vitamin D might attenuate SARS-CoV-2-induced lung injury.

      Vitamin D and acute lung injury

      Vitamin D and ACE2/RAS

      ARDS and acute lung injury are associated with high fatality rates in patients affected by SARS-CoV-2 and SARS-CoV. ARDS and acute lung injury are associated with damaged pulmonary microvascular endothelial cells (PMVECs), which result in increased alveolar permeability and pulmonary edema (
      • Su X.
      • Wang L.
      • Song Y.L.
      • Bai C.X.
      Inhibition of inflammatory responses by ambroxol, a mucolytic agent, in a murine model of acute lung injury induced by lipopolysaccharide.
      ). The balance between the expression of ACE1 and ACE2 is closely related to the ratio of Ang Ⅱ:Ang 1-7; an imbalance of Ang Ⅱ:Ang1-7 can lead to acute lung injury (
      • Gao X.
      • Xu H.
      • Zhang B.
      • Tao T.
      • Liu Y.
      • Xu D.
      • et al.
      Interaction of N-acetyl-seryl-aspartyl-lysyl-proline with the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis attenuates pulmonary fibrosis in silicotic rats.
      ,
      • Queiroz-Junior C.M.
      • Menezes Santos A.C.P.
      • Galvao I.
      • Souto G.R.
      • Mesquita R.A.
      • Sa M.A.
      • et al.
      The angiotensin converting enzyme 2/angiotensin-(1-7)/Mas receptor axis as a key player in alveolar bone remodeling.
      ,
      • Wang Y.
      • Wu H.
      • Niu W.
      • Chen J.
      • Liu M.
      • Sun X.
      • et al.
      Tanshinone IIA attenuates paraquat-induced acute lung injury by modulating angiotensin-converting enzyme 2/angiotensin-(1-7) in rats.
      ).
      Increasing evidence indicates that 1,25(OH)D inhibits the RAS (
      • Ali R.M.
      • Al-Shorbagy M.Y.
      • Helmy M.W.
      • El-Abhar H.S.
      Role of Wnt4/beta-catenin, Ang II/TGF beta, ACE2, NF-kappa B, and IL-18 in attenuating renal ischemia/reperfusion-induced injury in rats treated with Vit D and pioglitazone.
      ,
      • Cui C.
      • Xu P.
      • Li G.
      • Qiao Y.
      • Han W.
      • Geng C.
      • et al.
      Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: role of renin-angiotensin system.
      ). The renoprotection of vitamin D is likely mediated by inhibiting the RAS, Ang Ⅱ, and NF-kB, with a subsequent reduction in proinflammatory cytokines, such as IL-18 and TGF-β (
      • Ali R.M.
      • Al-Shorbagy M.Y.
      • Helmy M.W.
      • El-Abhar H.S.
      Role of Wnt4/beta-catenin, Ang II/TGF beta, ACE2, NF-kappa B, and IL-18 in attenuating renal ischemia/reperfusion-induced injury in rats treated with Vit D and pioglitazone.
      ). After binding to Ang Ⅱ, AT1aR triggers NADPH oxidase (Nox) activation and generates reactive oxygen species (ROS) (
      • Cui C.
      • Xu P.
      • Li G.
      • Qiao Y.
      • Han W.
      • Geng C.
      • et al.
      Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: role of renin-angiotensin system.
      ). VDR activation can inhibit the RAS to mediate antioxidant and anti-inflammatory effects (
      • Cui C.
      • Xu P.
      • Li G.
      • Qiao Y.
      • Han W.
      • Geng C.
      • et al.
      Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: role of renin-angiotensin system.
      ).
      VDR is widely distributed in lung cells. Vitamin D can alleviate acute lung injury by regulating RAS signalling (
      • Xu J.
      • Yang J.
      • Chen J.
      • Luo Q.
      • Zhang Q.
      • Zhang H.
      Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system.
      ). Pretreatment with calcitriol, a vitamin D agonist, significantly alleviated LPS-induced acute lung injury by upregulating ACE2 and downregulating ACE1, Ang Ⅱ, and AT1aR in an animal model (
      • Xu J.
      • Yang J.
      • Chen J.
      • Luo Q.
      • Zhang Q.
      • Zhang H.
      Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system.
      ) (Figure 4). Chronic vitamin D deficiency may activate the RAS and lead to lung fibrosis (
      • Zhou C.
      • Lu F.
      • Cao K.
      • Xu D.
      • Goltzman D.
      • Miao D.
      Calcium-independent and 1,25(OH)(2)D(3)-dependent regulation of the renin-angiotensin system in 1 alpha-hydroxylase knockout mice.
      ).
      Figure 4
      Figure 4Vitamin D protects against acute lung injury. Green: increased expression or promotion by vitamin D. Red: decreased expression or inhibition by vitamin D. VDR = vitamin D receptor, VDREs = vitamin D responsive elements. Binding to the VDREs induces and represses the transcription of many genes.

      Vitamin D and inflammatory cytokines

      Vitamin D can significantly decrease inflammatory cytokines, such as TNF-α, IL-8, IL-6, and IFN-β, when exposed to influenza virus (Figure 5) (
      • Khare D.
      • Godbole N.M.
      • Pawar S.D.
      • Mohan V.
      • Pandey G.
      • Gupta S.
      • et al.
      Calcitriol 1, 25 OH 2 D3 pre- and post-treatment suppresses inflammatory response to influenza A (H1N1) infection in human lung A549 epithelial cells.
      ). In addition, IFN-β was downregulated after RSV-infected human airway epithelial cells were treated with vitamin D (
      • Hansdottir S.
      • Monick M.M.
      • Lovan N.
      • Powers L.
      • Gerke A.
      • Hunninghake G.W.
      Vitamin D Decreases respiratory syncytial virus induction of NF-kappa B-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state.
      ). IL-8, an endogenous chemotactic factor for neutrophils, is overexpressed in acute lung injury. Furthermore, 1,25(OH)2D3 can inhibit neutrophil infiltration and alleviate acute lung injury by downregulating IL-8 (
      • Takano Y.
      • Mitsuhashi H.
      • Ueno K.
      1 alpha,25-Dihydroxyvitamin D-3 inhibits neutrophil recruitment in hamster model of acute lung injury.
      ). Vitamin D/VDR signalling plays an important role in alleviating alveolar permeability and pulmonary edema by decreasing proinflammatory cytokines (
      • Shi Y.-Y.
      • Liu T.-J.
      • Fu J.-H.
      • Xu W.
      • Wu L.L.
      • Hou A.N.
      • et al.
      Vitamin D/VDR signaling attenuates lipopolysaccharide-induced acute lung injury by maintaining the integrity of the pulmonary epithelial barrier.
      ).
      Figure 5
      Figure 5The possible mechanism by which vitamin D influences SARS-CoV-2.

      Vitamin D and antimicrobial peptides

      Vitamin D can induce the expression of antimicrobial peptides, which also have antiviral activity. Vitamin D has been reported to bind to VDR and then increase the human cathelicidin peptide LL37 and human β‐defensins (HBDs) in macrophages (
      • Teymoori-Rad M.
      • Shokri F.
      • Salimi V.
      • Marashi S.M.
      The interplay between vitamin D and viral infections.
      ) (Figure 5). LL37 can modulate Toll-like receptor (TLR) signalling and regulate inflammation (
      • Schogler A.
      • Muster R.J.
      • Kieninger E.
      • Casaulta C.
      • Tapparel C.
      • Jung A.
      • et al.
      Vitamin D represses rhinovirus replication in cystic fibrosis cells by inducing LL-37.
      ).
      Collectively, vitamin D and SARS-CoV-2 can affect the same target, ACE2. Vitamin D might alleviate acute lung injury and ARDS induced by SARS-CoV-2 by regulating the RAS/ACE2 pathway, inflammatory cytokines, and antimicrobial peptides (Future 5).

      Role of vitamin D supplementation in COVID-19 patients

      Vitamin D supplementation might serve as a treatment to improve clinical outcomes in COVID-19 patients. A previous report showed that 1,25(OH)D is inversely correlated with the risk of ARDS, heart failure, and diabetes mellitus (
      • Grant W.B.
      • Lahore H.
      • McDonnell S.L.
      • Baggerly C.A.
      • French C.B.
      • Aliano J.L.
      • et al.
      Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 Infections and Deaths.
      ).
      • Ohaegbulam K.C.
      • Swalih M.
      • Patel P.
      • Smith M.A.
      • Perrin R.
      Vitamin D supplementation in COVID-19 patients: a clinical case series.
      ) reported four vitamin d-deficient COVID-19 patients who received treatment with vitamin D supplementation. The clinical outcomes included increased vitamin D levels, shorter lengths of hospital stay, lower oxygen requirements, and reduced inflammatory markers. A questionnaire-based study in Italy reported that vitamin D supplementation reduced the prevalence of COVID-19 infection (odds ratio 0.56; 95% confidence interval 0.32–0.99; p = 0.048) (
      • Fasano A.
      • Cereda E.
      • Barichella M.
      • Cassani E.
      • Ferri V.
      • Zecchinelli A.L.
      • et al.
      COVID-19 in Parkinson’s disease patients living in Lombardy, Italy.
      ).

      Conclusion and future perspectives

      Since ACE2 is the host cell receptor for both SARS-CoV-2 and SARS-CoV, regulating the ACE2/RAS system may alleviate lung injury caused by SARS-CoV-2 as well as SARS-CoV. Vitamin D was found to affect ACE2, the target of SARS-CoV-2. We speculate that vitamin D might alleviate lung injury induced by SARS-CoV-2 by upregulating ACE2, decreasing inflammatory cytokines, and increasing antimicrobial peptides. The efficacy of vitamin D in treatment of SARS-CoV-2 needs to be verified through more evidence-based medicine. In the future, we hope that randomized controlled clinical trials can be carried out to achieve this.

      Ethical approval and consent to participate

      Not applicable; review.

      Consent for publication

      Not applicable; review.

      Clinical trial registration number and date if applicable

      Not applicable; review.

      Availability of data and material

      No additional data are available.

      Conflict of interest

      The authors declare that they have no competing financial interests.

      Funding sources

      This work was supported by the National Science Foundation of China (81971433, 81971428, 82001593, 82071353) and a grant from the Clinical Discipline Program (Neonatology) from the Ministry of Health of China (1311200003303).

      Author information

      Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, China; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu 610041, China.

      CRediT authorship contribution statement

      Dongqiong Xiao: Conceptualization, Software, Validation, Investigation, Resources, Writing - original draft, Writing - review & editing. Xihong Li: Conceptualization, Software, Validation, Investigation, Resources, Writing - original draft, Writing - review & editing. Xiaojuan Su: Software, Validation, Investigation, Resources, Writing - review & editing. Dezhi Mu: Software, Validation, Investigation, Resources, Writing - review & editing, Visualization, Supervision, Funding acquisition. Yi Qu: Conceptualization, Software, Validation, Investigation, Resources, Writing - review & editing, Visualization, Supervision, Funding acquisition.

      References

        • Ali R.M.
        • Al-Shorbagy M.Y.
        • Helmy M.W.
        • El-Abhar H.S.
        Role of Wnt4/beta-catenin, Ang II/TGF beta, ACE2, NF-kappa B, and IL-18 in attenuating renal ischemia/reperfusion-induced injury in rats treated with Vit D and pioglitazone.
        Eur J Pharmacol. 2018; 831: 68-76
        • Bao L.
        • Deng W.
        • Huang B.
        • Gao H.
        • Liu J.
        • Ren L.
        • et al.
        The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.
        Nature. 2020;
        • Bertram S.
        • Glowacka I.
        • Mueller M.A.
        • Lavender H.
        • Gnirss K.
        • Nehlmeier I.
        • et al.
        Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease.
        J Virol. 2011; 85: 13363-13372
        • Biscayart C.
        • Angeleri P.
        • Lloveras S.
        • Chaves T.d.S.S.
        • Schlagenhauf P.
        • Rodriguez-Morales A.J.
        The next big threat to global health? 2019 novel coronavirus (2019-nCoV): What advice can we give to travellers?—Interim recommendations January 2020, from the Latin-American society for Travel Medicine (SLAMVI).
        Travel Med Infect Dis. 2020; (101567–)
        • Bobeck K.A.
        • Holtzclaw A.W.
        • Brown T.E.
        • Clark P.A.
        Effective use of angiotensin II in coronavirus disease 19-associated mixed shock state: a case report.
        A A Pract. 2020; 14e01221
        • Castilletti C.
        • Bordi L.
        • Lalle E.
        • Rozera G.
        • Poccia F.
        • Agrati C.
        • et al.
        Coordinate induction of IFN-alpha and -gamma by SARS-CoV also in the absence of virus replication.
        Virology. 2005; 341: 163-169
        • Chen I.Y.
        • Chang S.C.
        • Wu H.-Y.
        • Yu T.-C.
        • Wei W.-C.
        • Lin S.
        • et al.
        Upregulation of the chemokine (C-C motif) ligand 2 via a severe acute respiratory syndrome coronavirus spike-ACE2 signaling pathway.
        J Virol. 2010; 84: 7703-7712
        • Cheng H.
        • Wang Y.
        • Wang G.Q.
        Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
        J Med Virol. 2020; 92: 726-730
        • Cui C.
        • Xu P.
        • Li G.
        • Qiao Y.
        • Han W.
        • Geng C.
        • et al.
        Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: role of renin-angiotensin system.
        Redox Biol. 2019; : 26
        • Fasano A.
        • Cereda E.
        • Barichella M.
        • Cassani E.
        • Ferri V.
        • Zecchinelli A.L.
        • et al.
        COVID-19 in Parkinson’s disease patients living in Lombardy, Italy.
        Mov Disord. 2020; 35: 1089-1093
        • Fitzgerald M.
        • Shyamsundar M.
        • McNamee J.J.
        • Thickett D.R.
        • O’Kane C.M.
        • McAuley D.F.
        Vitamin D deficiency drives pulmonary inflammation in a human model of the acute respiratory distress syndrome induced by inhaled lipopolysaccharide in healthy volunteers.
        Thorax. 2015; 70 (A40–A)
        • Gao X.
        • Xu H.
        • Zhang B.
        • Tao T.
        • Liu Y.
        • Xu D.
        • et al.
        Interaction of N-acetyl-seryl-aspartyl-lysyl-proline with the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis attenuates pulmonary fibrosis in silicotic rats.
        Exp Physiol. 2019; 104: 1562-1574
        • Ge X.-Y.
        • Li J.-L.
        • Yang X.-L.
        • Chmura A.A.
        • Zhu G.
        • Epstein J.H.
        • et al.
        Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor.
        Nature. 2013; 503 (535–+)
        • Gou X.
        • Pan L.
        • Tang F.
        • Gao H.
        • Xiao D.
        The association between vitamin D status and tuberculosis in children: a meta-analysis.
        Medicine (Baltimore). 2018; 97e12179
        • Grant W.B.
        • Lahore H.
        • McDonnell S.L.
        • Baggerly C.A.
        • French C.B.
        • Aliano J.L.
        • et al.
        Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 Infections and Deaths.
        Nutrients. 2020; 12
        • Gui M.
        • Song W.
        • Zhou H.
        • Xu J.
        • Chen S.
        • Xiang Y.
        • et al.
        Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding.
        Cell Res. 2017; 27: 119-129
        • Guo X.
        • Chen Z.
        • Xia Y.
        • Lin W.
        • Li H.
        Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2).
        J Transl Med. 2020; 18: 321
        • Haga S.
        • Nagata N.
        • Okamura T.
        • Yamamoto N.
        • Sata T.
        • Yamamoto N.
        • et al.
        TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds.
        Antiviral Res. 2010; 85: 551-555
        • Hansdottir S.
        • Monick M.M.
        • Lovan N.
        • Powers L.
        • Gerke A.
        • Hunninghake G.W.
        Vitamin D Decreases respiratory syncytial virus induction of NF-kappa B-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state.
        J Immunol. 2010; 184: 965-974
        • Hu B.
        • Huang S.
        • Yin L.
        The cytokine storm and COVID-19.
        J Med Virol. 2020;
        • Ilie P.C.
        • Stefanescu S.
        • Smith L.
        The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality.
        Aging Clin Exp Res. 2020;
        • Imai Y.
        • Kuba K.
        • Penninger J.M.
        The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice.
        Exp Physiol. 2008; 93: 543-548
        • Jin Y.-H.
        • Cai L.
        • Cheng Z.-S.
        • Cheng Z.-S.
        • Deng T.
        • Fan Y.-P.
        • et al.
        A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version).
        Military Med Res. 2020; 7 (4)
        • Khare D.
        • Godbole N.M.
        • Pawar S.D.
        • Mohan V.
        • Pandey G.
        • Gupta S.
        • et al.
        Calcitriol 1, 25 OH 2 D3 pre- and post-treatment suppresses inflammatory response to influenza A (H1N1) infection in human lung A549 epithelial cells.
        Eur J Nutr. 2013; 52: 1405-1415
        • Kuba K.
        • Imai Y.
        • Penninger J.M.
        Angiotensin-converting enzyme 2 in lung diseases.
        Curr Opin Pharmacol. 2006; 6: 271-276
        • Lee M.-D.
        • Lin C.-H.
        • Lei W.-T.
        • Chang H.-Y.
        • Lee H.-C.
        • Yeung C.-Y.
        • et al.
        Does vitamin D deficiency affect the immunogenic responses to influenza vaccination? A systematic review and meta-analysis.
        Nutrients. 2018; 10
        • Li F.
        Receptor recognition and cross-species infections of SARS coronavirus.
        Antiviral Res. 2013; 100: 246-254
        • Li X.
        • Wang W.
        • Zhao X.
        • Zai J.
        • Zhao Q.
        • Li Y.
        • et al.
        Transmission dynamics and evolutionary history of 2019-nCoV.
        J Med Virol. 2020;
        • Li X.
        • Zai J.
        • Wang X.
        • Li Y.
        Potential of large’ first generation’ human-to-human transmission of 2019-nCoV.
        J Med Virol. 2020;
        • Li Y.
        • Zeng Z.
        • Cao Y.
        • Liu Y.
        • Ping F.
        • Liang M.
        • et al.
        Angiotensin-converting enzyme 2 prevents lipopolysaccharide-induced rat acute lung injury via suppressing the ERK1/2 and NF-kappa B signaling pathways.
        Sci Rep. 2016; : 6
        • Lingappan K.
        • Karmouty-Quintana H.
        • Davies J.
        • Akkanti B.
        • Harting M.T.
        Understanding the age divide in COVID-19: why are children overwhelmingly spared?.
        Am J Physiol Lung Cell Mol Physiol. 2020; 319: L39-L44
        • Liu P.
        • Tan X.-Z.
        2019 Novel coronavirus (2019-nCoV) pneumonia.
        Radiology. 2020; (200257–.)
        • Liu W.
        • Morse J.S.
        • Lalonde T.
        • Xu S.
        Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV.
        Chembiochem. 2020;
        • Liu Y.
        • Yang Y.
        • Zhang C.
        • Huang F.
        • Wang F.
        • Yuan J.
        • et al.
        Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury.
        Sci China Life Sci. 2020;
        • Martineau A.R.
        • Jolliffe D.A.
        • Greenberg L.
        • Aloia J.F.
        • Bergman P.
        • Dubnov-Raz G.
        • et al.
        Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis.
        Health Technol Assess. 2019; 23 (1–+)
        • Mueller M.A.
        • Raj V.S.
        • Muth D.
        • Meyer B.
        • Kallies S.
        • Smits S.L.
        • et al.
        Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines.
        Mbio. 2012; 3
        • Ohaegbulam K.C.
        • Swalih M.
        • Patel P.
        • Smith M.A.
        • Perrin R.
        Vitamin D supplementation in COVID-19 patients: a clinical case series.
        Am J Ther. 2020; 27: e485-e490
        • Orwoll E.
        • Nielson C.M.
        • Marshall L.M.
        • Lambert L.
        • Holton K.F.
        • Hoffman A.R.
        • et al.
        Vitamin D deficiency in older men.
        J Clin Endocrinol Metabol. 2009; 94: 1214-1222
        • Pak J.E.
        • Sharon C.
        • Satkunarajah M.
        • Auperin T.C.
        • Cameron C.M.
        • Kelvin D.J.
        • et al.
        Structural insights into immune recognition of the severe acute respiratory syndrome coronavirus S protein receptor binding domain.
        J Mol Biol. 2009; 388: 815-823
        • Queiroz-Junior C.M.
        • Menezes Santos A.C.P.
        • Galvao I.
        • Souto G.R.
        • Mesquita R.A.
        • Sa M.A.
        • et al.
        The angiotensin converting enzyme 2/angiotensin-(1-7)/Mas receptor axis as a key player in alveolar bone remodeling.
        Bone. 2019; : 128
        • Russell C.D.
        • Millar J.E.
        • Baillie J.K.
        Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.
        Lancet (London, England). 2020;
        • Schogler A.
        • Muster R.J.
        • Kieninger E.
        • Casaulta C.
        • Tapparel C.
        • Jung A.
        • et al.
        Vitamin D represses rhinovirus replication in cystic fibrosis cells by inducing LL-37.
        Eur Respir J. 2016; 47: 520-530
        • Science M.
        • Maguire J.L.
        • Russell M.L.
        • Smieja M.
        • Walter S.D.
        • Loeb M.
        Low serum 25-hydroxyvitamin D level and risk of upper respiratory tract infection in children and adolescents.
        Clin Infect Dis. 2013; 57: 392-397
        • Senapati S.
        • Kumar S.
        • Singh A.K.
        • Banerjee P.
        • Bhagavatula S.
        Assessment of risk conferred by coding and regulatory variations of TMPRSS2 and CD26 in susceptibility to SARS-CoV-2 infection in human.
        J Genet. 2020; 99
        • Shi Y.-Y.
        • Liu T.-J.
        • Fu J.-H.
        • Xu W.
        • Wu L.L.
        • Hou A.N.
        • et al.
        Vitamin D/VDR signaling attenuates lipopolysaccharide-induced acute lung injury by maintaining the integrity of the pulmonary epithelial barrier.
        Mol Med Rep. 2016; 13: 1186-1194
        • Sieńko J.
        • Kotowski M.
        • Bogacz A.
        • Lechowicz K.
        • Drożdżal S.
        • Rosik J.
        • et al.
        COVID-19: The influence of ACE genotype and ACE-I and ARBs on the course of SARS-CoV-2 infection in elderly patients.
        Clin Interv Aging. 2020; 15: 1231-1240
        • Song P.
        • Li W.
        • Xie J.
        • Hou Y.
        • You C.
        Cytokine storm induced by SARS-CoV-2.
        Clin Chim Acta. 2020; 509: 280-287
        • Struck A.-W.
        • Axmann M.
        • Pfefferle S.
        • Drosten C.
        • Meyer B.
        A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2.
        Antiviral Res. 2012; 94: 288-296
        • Su X.
        • Wang L.
        • Song Y.L.
        • Bai C.X.
        Inhibition of inflammatory responses by ambroxol, a mucolytic agent, in a murine model of acute lung injury induced by lipopolysaccharide.
        Intensive Care Med. 2004; 30: 133-140
        • Taha M.M.
        • Shahy E.M.
        • Mahdy-Abdallah H.
        • Ibrahim K.S.
        • El Tahlawy E.M.
        Evaluation of the effect of serum cystatin-C and ACE I/D and ACE G2350A polymorphisms on kidney function among hypertensive sewage workers.
        Environ Sci Pollut Res Int. 2020;
        • Takano Y.
        • Mitsuhashi H.
        • Ueno K.
        1 alpha,25-Dihydroxyvitamin D-3 inhibits neutrophil recruitment in hamster model of acute lung injury.
        Steroids. 2011; 76: 1305-1309
        • Teymoori-Rad M.
        • Shokri F.
        • Salimi V.
        • Marashi S.M.
        The interplay between vitamin D and viral infections.
        Rev Med Virol. 2019; 29
        • Wan Y.
        • Shang J.
        • Graham R.
        • Baric R.S.
        • Li F.
        Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS.
        J Virol. 2020;
        • Wang J.
        • Jiang M.
        • Chen X.
        • Montaner L.J.
        Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts.
        J Leukoc Biol. 2020; 108: 17-41
        • Wang Y.
        • Wu H.
        • Niu W.
        • Chen J.
        • Liu M.
        • Sun X.
        • et al.
        Tanshinone IIA attenuates paraquat-induced acute lung injury by modulating angiotensin-converting enzyme 2/angiotensin-(1-7) in rats.
        Mol Med Rep. 2018; 18: 2955-2962
        • Wrapp D.
        • Wang N.
        • Corbett K.S.
        • Goldsmith J.A.
        • Hsieh C.L.
        • Abiona O.
        • et al.
        Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.
        Science. 2020; 367: 1260-1263
        • Wu A.
        • Peng Y.
        • Huang B.
        • Ding X.
        • Wang X.
        • Niu P.
        • et al.
        Genome composition and divergence of the novel coronavirus (2019-nCoV) Originating in China.
        Cell Host Microbe. 2020;
        • Wu Y.
        Compensation of ACE2 function for possible clinical management of 2019-nCoV-induced acute lung injury.
        Virologica Sinica. 2020;
        • Xiao D.
        • Zhang X.
        • Ying J.
        • Zhou Y.
        • Li X.
        • Mu D.
        • et al.
        Association between vitamin D status and sepsis in children: a meta-analysis of observational studies.
        Clin Nutr (Edinburgh, Scotland). 2019;
        • Xie X.D.
        • Chen J.Z.
        • Wang X.X.
        • Zhang F.R.
        • Liu Y.R.
        Age- and gender-related difference of ACE2 expression in rat lung.
        Life Sci. 2006; 78: 2166-2171
        • Xu J.
        • Yang J.
        • Chen J.
        • Luo Q.
        • Zhang Q.
        • Zhang H.
        Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system.
        Mol Med Rep. 2017; 16: 7432-7438
        • Ye Q.
        • Wang B.
        • Mao J.
        The pathogenesis and treatment of the’ cytokine storm’ in COVID-19.
        J Infect. 2020; 80: 607-613
        • Zhang X.
        • Li S.
        • Niu S.
        ACE2 and COVID-19 and the resulting ARDS.
        Postgrad Med J. 2020; 96: 403-407
        • Zhang Y.C.
        • Li J.
        • Zhan Y.L.
        • Wu L.Q.
        • Yu X.Y.
        • Zhang W.J.
        • et al.
        Analysis of serum cytokines in patients with severe acute respiratory syndrome.
        Infect Immunity. 2004; 72: 4410-4415
        • Zhou C.
        • Lu F.
        • Cao K.
        • Xu D.
        • Goltzman D.
        • Miao D.
        Calcium-independent and 1,25(OH)(2)D(3)-dependent regulation of the renin-angiotensin system in 1 alpha-hydroxylase knockout mice.
        Kidney Int. 2008; 74: 170-179
        • Zhou P.
        • Yang X.-L.
        • Wang X.-G.
        • Hu B.
        • Zhang L.
        • Zhang W.
        • et al.
        A pneumonia outbreak associated with a new coronavirus of probable bat origin.
        Nature. 2020;
        • Ziegler T.
        • Matikainen S.
        • Ronkko E.
        • Osterlund P.
        • Sillanpaa M.
        • Siren J.
        • et al.
        Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune responses in cultured human monocyte-derived dendritic cells.
        J Virol. 2005; 79: 13800-13805
        • Zou Z.
        • Yan Y.
        • Shu Y.
        • Gao R.
        • Sun Y.
        • Li X.
        • et al.
        Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections.
        Nat Commun. 2014; : 5
        • Zumla A.
        • Hui D.S.
        • Azhar E.I.
        • Memish Z.A.
        • Maeurer M.
        Reducing mortality from 2019-nCoV: host-directed therapies should be an option.
        Lancet (London, England). 2020;